• Industry News
  • Law & Malpractice
  • Coding & Documentation
  • Practice Management
  • Finance
  • Technology
  • Patient Engagement & Communications
  • Billing & Collections
  • Staffing & Salary

4 Easy Steps to Qualify for Meaningful Use

Article

In this easy-to-follow, presentation you will learn about the practical benefits of Meaningful Use and how you can qualify for Meaningful Use funds.

ADP AdvancedMD is one of the nation's largest providers of cloud medical practice optimization software offering a fully integrated EHR and Practice Management solution, and is a subsidiary of Automatic Data Processing, Inc. (NASDAQ:ADP ). ADP, with nearly $9 billion in revenues and about 550,000 clients, is one of the world's largest providers of business outsourcing solutions. Leveraging more than 60 years of experience, ADP offers a wide range of HR, payroll, tax and benefits administration solutions from a single source. ADP's easy-to-use solutions for employers provide superior value to companies of all types and sizes. ADP is also a leading provider of integrated computing solutions to auto, truck, motorcycle, marine and recreational vehicle dealers throughout the world. For more information about ADP AdvancedMD, call (800) 825-0224 or visit: www.advancedmd.com.

In this easy-to-follow, presentation you will learn about the practical benefits of Meaningful Use and how you can qualify for Meaningful Use funds.

This webinar provides an informative overview of Meaningful Use and how a practice can qualify for, and collect, stimulus funds. It also demonstrates how ADP® AdvancedMD® cloud EHR software meets all Meaningful Use requirements, and how partnering with ADP AdvancedMD can help you run a more efficient, patient-focused, and profitable practice.

Click to view this video

Related Videos
The importance of vaccination
The fear of inflation and recession
Protecting your practice
Protecting your home, business while on vacation
Protecting your assets during the 100 deadly days
Payment issues on the horizon
The future of Medicare payments
MGMA comments on automation of prior authorizations
The burden of prior authorizations
Strategies for today's markets
© 2024 MJH Life Sciences

All rights reserved.